THE Pharmacy Board of Australia has provided an update on the development of revised guidance on expiry of compounded parenteral medicines.
Submissions received during the Feb-Mar 2016 consultation are now published on the Board's website, with revised guidance to be published upon conclusion of the board's deliberations in 2017.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Dec 16
